iKure Techsoft Private Limited has secured USD 1.8 million in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation—facilitated through We Share Forward and Prourgn LLC, Japan. Each organisation independently evaluated iKure’s healthcare delivery model, technology platform and ability to execute at scale before committing to the round.
The investment will help in ensuring that screening and diagnosis lead to continuous care. Diabetes, hypertension and maternal health complications require sustained monitoring and follow-up. iKure addresses this gap by combining trusted community health workers with longitudinal patient records, enabling care to continue beyond the first consultation.
